Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
7.09
-0.53 (-6.96%)
Dec 5, 2025, 4:00 PM EST - Market closed
Bioventus Market Cap
Bioventus has a market cap or net worth of $474.86 million as of December 5, 2025. Its market cap has decreased by -35.43% in one year.
Market Cap
474.86M
Enterprise Value
773.87M
1-Year Change
-35.43%
Ranking
Category
Stock Price
$7.09
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $474.86M, a decrease of -33.44%. That is a compound annual growth rate of -8.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 510.36M | -25.64% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 | 713.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.92B |
| Johnson & Johnson | 496.77B |
| AbbVie | 398.44B |
| UnitedHealth Group | 295.42B |
| AstraZeneca | 282.37B |
| Merck & Co. | 253.46B |
| Novartis AG | 253.36B |
| Abbott Laboratories | 220.51B |